Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Merck
Farmers Insurance
Citi
Covington
UBS
Cerilliant
Fish and Richardson
US Department of Justice

Generated: June 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086831

« Back to Dashboard

NDA 086831 describes CHLORTHALIDONE, which is a drug marketed by Abbott, Ascot, Barr Labs Inc, Dava Pharms Inc, G And W Labs Inc, Ivax Pharms, Kv Pharm, Mutual Pharm, Mylan, Pioneer Pharms, Purepac Pharm, Riconpharma Llc, Sandoz, Sun Pharm Industries, Superpharm, Umedica Labs Pvt Ltd, Usl Pharma, Vangard, Warner Chilcott, and Watson Labs, and is included in forty-five NDAs. It is available from twenty suppliers. Additional details are available on the CHLORTHALIDONE profile page.

The generic ingredient in CHLORTHALIDONE is chlorthalidone. There are nineteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
Summary for 086831
Tradename:CHLORTHALIDONE
Applicant:Mylan
Ingredient:chlorthalidone
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 086831
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for 086831
Suppliers and Packaging for NDA: 086831
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLORTHALIDONE chlorthalidone TABLET;ORAL 086831 ANDA Mylan Pharmaceuticals Inc. 0378-0213 N 0378-0213-01
CHLORTHALIDONE chlorthalidone TABLET;ORAL 086831 ANDA Mylan Pharmaceuticals Inc. 0378-0213 N 0378-0213-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Daiichi Sankyo
Dow
Covington
Federal Trade Commission
Johnson and Johnson
Mallinckrodt
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.